Reddit Posts
ELEV , low float potential upside?
Elevation Oncology, Inc. (NASDAQ:ELEV) low float?
Elevation Oncology, Inc. (ELEV)
💰Good morning! #premarket #watchlist 05/25 $MICS -secondary offering filing S1 active, $VRCA -getting second complete response FDA letter, $ELEV -FDA Fast Track Designation Granted to Seribantumab, $MOTS -Positive Topline Data From EU Study of the Pure-Vu System !
Mentions
I’ll take a look at ELEV
Next set of pinned tickers: NINE ELEV WAS AN INSD JOB
Next set of pinned tickers: NINE ELEV WAS AN INSD JOB
Next set of pinned tickers: NINE ELEV WAS AN INSD JOB
ELEV has a nice premarket bump, but after their sellout, I am not sure what would be a good exit price
hey guys can someone please help me understand something? ELEV got news that another company is buying them for 0.36 and now their price is around 0.39, isnt it obvious to sell the shares then? i dont under stand why would it make the stock go up
Going up: ELEV, STAI, HOVR, SES, CTM, LAES, SERV
I see potential x2 here. https://www.stocktitan.net/news/ELEV/elevation-oncology-enters-into-agreement-to-be-acquired-by-concentra-bh553fn386fq.html
Look at $ELEV, lots of insider trading and it failed trials and it's future is toast now.
LAES going! CTM, BBAI, ELEV, CLIR
ELEV a Bull Case for tomorrow, News expected!
MIST, ELEV, STSS, CISO, GORO, ICON and of course VVPR, to name a new
If $ELEV announces extension, it can jump to $2+ Keep an eye on it
Tell me about some Pennie’s you actually like long term and why you think that. I was looking at OPTT and it seems like something that isn’t just buzzwords and baloney. CTM seems like a solid option though I would expect a crowded space.. but it’s at least something I can understand and agree there is a demand for. ELEV is interesting cuz fuck cancer but can’t say I’m in tune with much else about it. I have more in my watchlist like CNFR, DGLY, MVIS, LITM, NVNI (this one really is barely hanging on my watchlist. Don’t like the tech buzzwords platform), and watching GORO for fun. I know there are no guarantees which is why these stocks are priced the way they are, but curious which ones you see a long term future in and why.
I like ELEV, but it’s a longer term play. They recently did a presentation about their clinical trials, sound promising, but still a ways off.
Does any one know if ELEV earnings report got out yet?
What do you guys think about ELEV?
The market is highly unstable right now. Many stocks with stronger earnings than this penny stock are underperforming, making it difficult to determine whether $ELEV has bottomed out.
IS ELEV this weeks play? 5th earnings report
I'm t-bagging ELEV, next week earnings report and cheap to hop on. NFA
BOSTON, Feb. 25, 2025 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced that members of management will participate in upcoming investor conferences in March: * **TD Cowen 45****^(th)** **Annual Health Care Conference.** Fireside chat on Tuesday, March 4, 2025 at 9:10 AM ET in Boston, MA. * **Leerink Global Biopharma Conference.** Fireside chat on Tuesday, March 11, 2025 at 8:40 AM ET in Miami, FL.
For those holding $ELEV🚨 The only news as of now is that they are having a conference in Boston march 4. No reverse split is being considered, first off they still can file for 180 day extension.
ELEV having earnings report in 7 days. so 5th of march. guess I hold one more week.....
ELEV has some action this morning. Not sure why though
I’ve got 5k shares in ELEV. I am hoping for some good news soon. I feel like this one is a good play. But the way it’s continuing a downtrend, I am skeptical to put more into it.
ELEV is in my long bag. Hopefully something good soon!
Massive buys on ELEV. probably one of the most safest penny stocks out there and it barely gets mentioned on here.
DGLY, ELEV, UNCY, SPGC, CNSP? Anyone?
The company is definitely undervalued. I do see gradually increasing volume but still not yet enough to take off. I am expecting to see increasing volume prior to earning, with good news ELEV would take off no doubt.
I have ELEV at .67; how high it could go? Some say way over 5$
Any UNCY or ELEV baggers around here? How yall doing?
Full support on ELEV with you!
Your post with title "Is ELEV still viable?" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
ELEV - to buy or not buy the dip 🤤 (I bought)
For starters with increased Vol and buying pressure I wouldn’t be surprised to see her shoot past $0.48 imho I mean comparable stock like ELEV and UNCY are sitting at around $0.60 Breakthroughs in lung cancer treatments, especially for EGFR mutations, attract strong investor interest because they target a significant patient population with high unmet needs. Just gonna ride the wave. If we keep up momentum and follow-through buying tomorrow things could get Sticky
ELEV is close to picking up traction at $0.62 currently with a $6-$10 price target for next January (allegedly). What do you guys think about it?
Slight Dip on ELEV, loaded up to 1400 shares 🤘 anyone else still in on it?
Interesting one, just had a look at ELEV, looks like a promising one but why has it been doing bad lately after it hit 5$?
ELEV for now, I’d say KULR is a good long term hold as well.
Yes, realistically I think it’ll trickle back up to $1 maybe 2, SPGC and ELEV are the only stocks I’m holding, rest is options
ELEV and SLCX!!! Say what you want...I'll regard myself if it fails 🤣🤣🤣
I know some of the ELEV people are excited this morning! Now let’s hope we start reaching at least $1
I like to check Reddit, discords, Stocktwits, charts, Robinhood buy rates, analysts price targets, GROK, ChatGPT, and just about everything else when you’re investing your money with companies, but the good news is, there’s nice communities who will help you out also online. Today i recommend $ELEV $ARBE $RCAT $REKR $AMPX $SLDB $LAES, this isn’t financial advice, but those are my biggest holdings for penny stocks currently
I'm in for LODE and ELEV 🤞
ELEV and LODE day tomorrow!! ELEV definitely going 1
ELEV needs to keep going today and make all of its investors weeks a little better!
I’m officially out of ELEV for a slight loss, straight into SPGC
$ELEV has private funding, has never had federal funding
I have said it in every ELEV thread, and I made a decent profit, but sold the day that the NIH fund freeze leaked. Personally, I have exited most biopharma until the NIH fund freeze and RFK Jr. process are over. Both of these market uncertainties have a super chilling effect on cancer research, specifically. Conversely, I have held biopharma which is not reliant on federal grants or fits the new administration’s profile, like NRXP and TNXP, both up 2x-3x.
Cool to see another post on $ELEV. Adding something I recently shared in another post. Considering the latest news about federal funding, Elevation Oncology has repeatedly raised funds through private and public channels without federal assistance. *I hope this will make people move money away from other biopharmaceutical plays where funding is federal to $ELEV, but I couldn't find any recent data on % of funding in this niche (private VS federal).* 2 of analysts are experts in the niche. You can find more info on their website in the section of investors. * Sudan N. Loganathan, PhD, Biotechnology Equity Research Analyst. * Ramakanth Swayampakula, PhD in Pharmacology. I am also monitoring their SEC filings, they have a section here: [https://investors.elevationoncology.com/sec-filings](https://investors.elevationoncology.com/sec-filings)
We need to see a .90 ELEV again so we can feel confident!
ELEV is probably one of the better biopharma penny stocks, NRXP is even better, but the Trump administration should make people reevaluate price targets. That $6 PT has been around for awhile, it does not consider the current uncertainty with funding freezes. I like ELEV, but I sold at profit because, as others noted, it will take awhile to go much higher, if it does.
Your post with title "Is ELEV cooked?" has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
SES and ELEV the only companies I trust in this thread
Be patient. ELEV is a play for the long haul. It has proven stability, cash to last through the year, and a new administration which is expected to rely heavily on American everything. Medicine included
TNXP, RIME, HEPA, EDBL and ELEV. Any thoughts on these?
TNXP, RIME, HEPA, EDBL and ELEV. Any thoughts on these?
What about RIME, ELEV and EDBL for coming monday? Total lottery tickets for me in a sense that if I go to 0 with them it doesn't really matter. But if they get like 300% or something, I make a few dollaaroos!
I’ve been following ELEV a bit. It looks way oversold and primed for a swing on the 3 month chart. That’s my main thought.
I found a good one for you guys: $ELEV
I see. How many shares are you holding atm & what's your average price? Do you have a PT in mind for ELEV?
ELEV has major catalysts coming. [Their Phase 1 trial of EO-3021 showed a 42.8% response rate in gastric cancer patients](https://beyondspx.com/article/elevation-oncology-elev-a-promising-oncology-innovator-advancing-a-differentiated-pipeline), way better than existing treatments. Plus they just [nominated EO-1022 as their HER3 ADC candidate](https://finance.yahoo.com/news/elevation-oncology-expands-pipeline-nomination-123000444.html) - this targets multiple cancer types including breast and lung cancer. $103M cash runway into 2026. More trial data coming in first half of 2025. The recent licensing deal with Synaffix for their ADC tech platform is huge for developing these cancer drugs. Not a matter of if but when this rebounds. Biotech always has ups and downs during trials. But ELEV's pipeline and cash position are solid.
People who followed me on MGX made a boatload. I got stopped out at a loss, and that is fine. All my trades are pre-run up, whatever the reason might be for the accumulation. All calls are free for all to read and use. I always disclose that I own the stock, and that I intend to add, reduce or dump it all as I see fit. Currently holding TRNR, ELEV, OMGA. Also own ICCT which already pumped once, so you can disregard it unless you want to hold longer term. Below is the post on MGX, and you can check the rest in my profile. [https://www.reddit.com/user/value1024/comments/1hadw9n/mgx\_long\_thesis\_has\_manifested\_congrats\_to\_longs/](https://www.reddit.com/user/value1024/comments/1hadw9n/mgx_long_thesis_has_manifested_congrats_to_longs/)
ELEV.. if you want to be extremely rich, join me on this
I'm trying to figure out what's going on with ELEV - anyone got insight on why it's results and earnings are causing a 60% drop?
ELEV keep oumping or taking an crap tomorrow?
$TLS looking to break $4.25. If it does, can it challenge the June high of $5? $ELEV hit the support at around $2.55 and is looking to make a higher high. If it does it can make a run into the $3.50 - $4.00 range.
Nice. Take a look at ELEV and VERU. I heard u/iJesusChrist likes dem stonks
I would argue understanding institutional investing is the key to "understanding" penny stocks. Hedge funds, banks, etc. Own %90 of all stocks. THEIR investment is what drives a stock through the rough, not us peasants. For example, many small biotech AI companies are making absurd claims for future growth. What is the most likely way to determine the validity of such claims? Where the money goes. Compair ELEV verses ICAD verses BFRG. ELEV stock jumped as institutions saw a reasonable risk/reward. Similarly, as markets sell-off, institutions are driving prices as they remove their exposure from higher risk companies (negative growth, no cash, etc.). Hope that helps.
I'm trying to find AI Biotech stocks. ELEV is a good contender.
Nio, ESPR, SKYT, ELEV, I’m just listing stocks under 10$ that I have made money on. You can definitely make money on these but they’re also basically penny stocks so you could lose your money in the blink of an eye. My gains so far 110% on ESPR, 37% on SKYT, 86% on ELEV.
I've aped into ELEV, then FGEN, then EQ, then JANX, now VKTX. I just follow u/drug_smolecules on twitter blindly tbh
Ik what WKHS is… I Also own a lot of LUCID stock too. My other bets are RKLB up abt 20% SKYT up abt 9% and ELEV up abt 17%. I also have some NVAX that I’m only up 1/4% on but will see I might have to cut this one if it dosent start moving up soon. I’m thinking they will reach profitability next quarter if so I’m keeping it if not I’m cutting.
How long did you watch ELEV before buying?
What do you think of HARP and AMAM valuation vs ELEV?
Is there a DD here about ELEV? Some one just posted about it in wsb I remember seeing it in penny stocks
ELEV you're welcome 🤗
ELEV, low float stock ready to pop? Elevation Oncology, Inc. is an oncology company. The Company is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 (SYSA1801 or CPO102), is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, a clinically validated molecular target, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Claudin 18.2 is expressed across several solid tumor types, including many gastrointestinal cancers such as gastric, gastroesophageal junction and pancreatic cancer. Claudin 18.2 is also expressed in ovarian cancer, non-small cell lung cancer (NSCLC) and other solid tumors. The Company is exploring opportunities through new or existing partnerships and business development opportunities to expand its novel oncology pipeline.
Anyone heard about $ELEV? Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition
No. ELEV is better, low float biotech play. The upside is unlimited.
Lol, ELEV is a better play, low float biotech play. The upside is unlimited.